ACM
BIIB icon

Argonaut Capital Management’s Biogen BIIB Stock Holding History

Argonaut Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$292K Hold
1,000
– – 0.98% 30
2015
Q2 		$404K Buy
+1,000
New +$401K 1.17% 24

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Argonaut Capital Management's BIIB Position: Q3 2015 in Review

Argonaut Capital Management held its Biogen (BIIB) position steady in Q3 2015 at 1,000 shares worth $292K. The position accounts for 0.98% of the portfolio, ranked #30.

Argonaut Capital Management first reported a position in BIIB in Q2 2015 and has held it in 2 quarters since. The position peaked at $404K in Q2 2015. 923 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Argonaut Capital Management held 1,000 shares of Biogen worth $292K as of Q3 2015.
  • Argonaut Capital Management left its Biogen share count unchanged in Q3 2015.
  • Biogen made up 0.98% of Argonaut Capital Management's portfolio in Q3 2015, its #30 holding.
  • Argonaut Capital Management first reported a position in Biogen in Q2 2015 and has held it in 2 quarters since.
  • Argonaut Capital Management's Biogen position peaked at $404K in Q2 2015.
  • 923 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Argonaut Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.